Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
China SXT Pharmaceuticals ( (SXTC) ) just unveiled an update.
On May 5, 2025, China SXT Pharmaceuticals entered into a securities purchase agreement with an investor to sell 200,000 Ordinary Shares, generating approximately $100,000 in gross proceeds. The transaction was completed on May 12, 2025, increasing the total outstanding shares to 16,027,758. This move is part of the company’s strategy to raise capital, potentially impacting its financial position and market operations.
More about China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the development and sale of traditional Chinese medicine products. The company is based in Taizhou, Jiangsu, China, and is involved in the production of various medicinal products aimed at addressing a range of health conditions.
Average Trading Volume: 4,103,822
Technical Sentiment Signal: Sell
Current Market Cap: $33.66M
For a thorough assessment of SXTC stock, go to TipRanks’ Stock Analysis page.